Connecticut is on track to allow access to medical cannabis for the treatment of female orgasmic disorder (FOD) following a decision on Friday by the state Medical Marijuana Program Board of Physicians.
Doctors on the state panel unanimously agreed that cannabis is more likely than not to have a beneficial effect on FOD, which they acknowledged as a debilitating condition. Orgasms in people with FOD are delayed, infrequent or entirely absent.
The body also signed off on a separate proposal to add autism spectrum disorder as a qualifying condition for Connecticut’s medical cannabis program.
The push to add FOD as a condition for marijuana access stems from a petition submitted last year by Suzanne Mulvehill, a clinical sexologist who’s working to expand access to cannabis for people with FOD.
The executive director of the Female Orgasm Research Institute and the related Women’s Cannabis Project, Mulvehill has published research indicating that cannabis use increased orgasm ease and frequency in more than 70 percent of patients with FOD. Her study also found that marijuana improved sexual satisfaction in about two thirds (67 percent) of those with FOD.
Despite the promising results, Mulvehill told the panel, discussing women’s sexual satisfaction still carries stigma.
“We rarely talk about this topic, but I think it’s time,” she said, “because up to 41 percent of women suffer from it, and that statistic has not changed for more than 50 years.”
Referencing drugs for erectile dysfunction, such as Viagra, Mulvehill argued that “there is a solution for men, you know, but there really isn’t one for women.”
“This can be that solution,” she said of medical marijuana.
Hellbound and Down 